TEVA PHARMACEUTICAL INDUSTRIES LTD·4

May 20, 7:09 AM ET

Halfon Jean Michel 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed May 20, 2019

Insider Transaction Report

Form 4
Period: 2019-05-16
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2019-05-16+2,7804,942 total
  • Exercise/Conversion

    Restricted Share Units

    2019-05-162,7800 total
    Ordinary Shares (2,780 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on May 16, 2016 and vested on May 16, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION